Nwam LLC Journey Medical Corp Transaction History

Nwam LLC

$1.6 Billion
Q3 2024

A detailed history of Nwam LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Nwam LLC holds 10,430 shares of DERM stock, worth $56,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,430

Holding current value

$56,113

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 12, 2024	BUY	$4.22 - $5.91 $44,014 - $61,641	10,430 New	10,430 $58,000
Q1 2024 May 09, 2024	BUY	$2.92 - $5.47 $34,514 - $64,655	11,820 New	11,820 $43,000

Others Institutions Holding DERM

# of Institutions

Shares Held

2.93M

Call Options Held

Put Options Held

B. Riley Securities, Inc. Los Angeles, CA

865K
Shares

$4.65 Million
0.36% of portfolio
Vanguard Group Inc Valley Forge, PA

325K
Shares

$1.75 Million
0.0% of portfolio
Cambridge Investment Research Advisors, Inc.

314K
Shares

$1.69 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

268K
Shares

$1.44 Million
0.0% of portfolio
American Financial Group Inc

180K
Shares

$968,400
0.44% of portfolio

View Full List

About Journey Medical Corp

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $62.4M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

More about DERM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account